$CAVR news out !! CHARLOTTE, N.C., March 16, 2022 (GLOBE

New Post Public Reply Private Reply Replies (0) Message Board
wazzzzup
283
$CAVR news out !! CHARLOTTE, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- LiveToBeHappy, Inc. (OTCM: CAVR, soon to be LTBH) (“LiveToBeHappy” or the “Company”), announces it is nearing the completion of its final diligence on its two largest acquisitions and is considering several lending proposals it’s received for as much as $30 Million. The planned funding will finance these transactions, plus new additional acquisitions, and put the company in a position to retire a significant number of common shares in the float.

Kevin Vincent Cox, Chief Executive Officer of LiveToBeHappy, Inc., commented, “The company expects to close in the next few weeks on the first financing tranche in the amount of $2 Million of Non-Toxic Debt.



We sought out a major financing package to re-capitalize the business, re-structure the balance sheet, and invest in a national public relations and marketing campaign to support our aggressive expansion plans several months ago. With the progress we’ve made in the last two weeks, e will be able to implement these game changing priorities quickly – including our plan to fund new and prior acquisition capital structures and return a large number of shares in the float back into the company’s treasury.”

“We are nearing the completion of diligence for our two largest acquisitions and with the lending deals we have seen, we should be able to finance these transactions with debt as opposed to equity. This funding should put the company in a position to retire a significant number of common shares currently in the float,” Grant Edwards, CFO, said.

The company projects $30 Million in revenue for 2022. We consider this a conservative estimate and will amend this number regularly as the company continues its growth and closes on targeted acquisitions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading